12:00 AM
 | 
Aug 29, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Celexa citalopram regulatory update

FDA issued drug safety communication to healthcare professionals and updated the label of Celexa citalopram to recommend against the use of the depression drug at doses >40 mg/day due...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >